Author Correction: The landscape of d16HER2 splice variant expression across HER2-positive cancers.

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 Apr 2020
Historique:
entrez: 26 4 2020
pubmed: 26 4 2020
medline: 26 4 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41598-020-63942-4 PMID: 32332837 PMC: PMC7181868
pubmed: 32332837
doi: 10.1038/s41598-020-63942-4
pii: 10.1038/s41598-020-63942-4
pmc: PMC7181868
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

7210

Commentaires et corrections

Type : ErratumFor

Auteurs

Chiara Costanza Volpi (CC)

Department of the Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Filippo Pietrantonio (F)

Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Faculty of Medicine, Oncology and Hemato-Oncology Department, Università degli Studi di Milano, Milan, Italy.

Annunziata Gloghini (A)

Department of the Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
ORCID: 0000-0002-7226-1942

Giovanni Fucà (G)

Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
ORCID: 0000-0002-1560-2253

Silvia Giordano (S)

Department of Oncology, University of Turin, Turin, Italy.
Candiolo Cancer Institute, FPO - IRCCS - Candiolo (TO), Turin, Italy.

Simona Corso (S)

Department of Oncology, University of Turin, Turin, Italy.
Candiolo Cancer Institute, FPO - IRCCS - Candiolo (TO), Turin, Italy.

Giancarlo Pruneri (G)

Department of the Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Maria Antista (M)

Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Chiara Cremolini (C)

Unit of Medical Oncology, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy.

Elena Fasano (E)

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Serena Saggio (S)

Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Simona Faraci (S)

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Maria Di Bartolomeo (M)

Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Filippo de Braud (F)

Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Faculty of Medicine, Oncology and Hemato-Oncology Department, Università degli Studi di Milano, Milan, Italy.

Massimo Di Nicola (M)

Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Elda Tagliabue (E)

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Serenella Maria Pupa (SM)

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. serenella.pupa@istitutotumori.mi.it.

Lorenzo Castagnoli (L)

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Classifications MeSH